CUREDM

curedm-logo

CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.

#SimilarOrganizations #People #Financial #Website #More

CUREDM

Industry:
Biopharma Biotechnology Medical

Founded:
2004-01-01

Address:
Wilmington, Delaware, United States

Country:
United States

Website Url:
http://www.curedm.com

Total Employee:
1+

Status:
Active

Contact:
610-645-6796

Total Funding:
4.6 M USD

Technology used in webpage:
Domain Not Resolving Google Apps For Business CPanel SSL Liquid Web Nginx 1.4 NameSilo DNS


Similar Organizations

acologix-logo

Acologix

Acologix is a biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

kirax-logo

Kirax

Kirax is a biopharmaceutical company developing specialty care therapies for oncology, pain, and other unmet medical needs.

Current Employees Featured

rita-el-hajj_image

Rita El-Hajj
Rita El-Hajj Founder @ CureDM
Founder

Founder


claresa-levetan_image

Claresa Levetan

loraine-upham_image

Loraine Upham

rita-el-hajj_image

Rita El-Hajj

Acquisitions List

Date Company Article Price
2013-09-11 AviaraMD AviaraMD acquired by CureDM N/A

Investors List

scientific-health-development-partners_image

Scientific Health Development Partners

Scientific Health Development Partners investment in Series B - CureDM

calvert-research-institute_image

Calvert Research Institute

Calvert Research Institute investment in Series B - CureDM

Official Site Inspections

http://www.curedm.com

Unable to get host informations!!!

Loading ...

More informations about "CureDM"

CureDM, Inc. - Researching a Cure for Diabetes

CureDM, Inc. is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. The …See details»

CureDM - Crunchbase Company Profile & Funding

Organization. CureDM . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. CureDM is a …See details»

Organization | CureDM

CureDM Report issue. For profit Phase 1. Founded: Wilmington DE United States ... Organization Overview. First Clinical Trial. 2012 NCT01638611. First Marketed Drug. None First NDA …See details»

CureDM, Inc.

CureDM shall be free to use or copy all other information in such communications, including ideas, inventions, concepts, techniques or know-how disclosed therein, for any purposes. …See details»

CureDM Company Profile 2024: Valuation, Investors, …

CureDM General Information Description. Operator of a biopharmaceutical company intended to develop new therapies that may prevent, ameliorate or …See details»

CureDM Company Profile - Office Locations, Competitors ... - Craft

CureDM is a biopharmaceutical company that provides therapies to treat diabetes. It develops Human proIslet Peptide (HIP), a peptide associated with the regeneration of insulin-producing …See details»

CureDM, Inc. - Researching a Cure for Diabetes

The CureDM management team is comprised of talented individuals with decades of experience in major pharmaceutical and biotech companies, combined with renowned clinical experience …See details»

CureDM - Overview, News & Similar companies | ZoomInfo.com

Feb 12, 2018 Who is CureDM. CureDM, Inc. is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the …See details»

CureDM - Ownership and Business Overview - Mergr

CureDM, Inc. is a clinical development of the novel peptide therapeutic, HIP2B, for the treatment of type 1 and type 2 diabetes. CureDM is based in Wilmington, Delaware. Company Summary. …See details»

CureDM - Products, Competitors, Financials, Employees, …

CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. On February 13, …See details»

CureDM - Company Profile - Tracxn

Nov 5, 2024 CureDM ranks 87th among 216 active competitors. 79 of its competitors are funded while 43 have exited. Overall, CureDM and its competitors have raised over $6.79B in funding …See details»

Curedm Group Holdings, LLC - govtribe.com

Organization/curedm. Categories Sector > Industry > Industry Group > Sub-Industry Health Care > Pharmaceuticals > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals SIC …See details»

CureDM - Funding, Financials, Valuation & Investors - Crunchbase

CureDM is a biopharmaceutical company developing therapies that can prevent, ameliorate and reverse diabetes. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»

CureDM Group Holdings, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for CureDM Group Holdings, LLC of Albuquerque, NM. Get the latest business insights from Dun & …See details»

SANOFI-AVENTIS : and CureDM Sign Exclusive Worldwide License …

Apr 8, 2010 About CureDM CureDM is a biopharmaceutical company focused on the discovery and development of new therapies that prevent, ameliorate, or reverse diseases of …See details»

CureDM Fact Sheet 4 071

CureDM is developing new, safe, effective therapies for diabetes mellitus (DM). The compounds under development have the potential to generate new insulin-producing cells within the …See details»

Research programme: diabetes therapeutics - CureDM

Apr 5, 2018 CureDM (a subsidiary of Boston Therapeutics) is developing therapeutics for the treatment of type 1 and type 2 diabetes mellitus. A lead agent has entered into Research …See details»

Cure Myotonic Dystrophy UK (@curedmcharity) - Instagram

Charity Organization. Cure DM supports families living with Myotonic Dystrophy, their caregivers and loved ones. We facilitate research, peer support, and raise awareness. ... Tomorrow …See details»

CureDM, Inc. Announces the Appointment of John H. Dillon, II to …

Oct 26, 2006 [email protected] CureDM, Inc. Announces the Appointment of John H. Dillon, II to the Board of Directors Wynnewood, Pennsylvania, Oct. 26, 2006 -- CureDM, Inc, a …See details»

Cure Myotonic Dystrophy UK Charity – Support, Awareness, …

Including scientific events we attend and present at, current clinical trial and study updates, and a link to the CureDM Medication Snapshot . Get Involved. Click the photo to learn about all the …See details»

linkstock.net © 2022. All rights reserved